miR-10b as a Clinical Marker and a Therapeutic Target for Metastatic Breast Cancer
Despite advances in cancer detection and treatment, metastatic breast cancer continues to carry a poor prognosis due to the lack of diagnostic and therapeutic resources that are specific to the metastatic process. MicroRNA-10b (miR-10b) is a small, noncoding RNA that is the focus of many studies due...
Saved in:
| Main Authors: | Alan Halim PhD, Bryan Kim BS, Elizabeth Kenyon MS, Anna Moore PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-05-01
|
| Series: | Technology in Cancer Research & Treatment |
| Online Access: | https://doi.org/10.1177/15330338251339256 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deregulation of Exosomal miR-17, miR-20a and TGFBR2 in Head and Neck Cancer Patients
by: Muhammad Rizwan PhD, et al.
Published: (2025-02-01) -
Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors
by: M. S. Knyazeva, et al.
Published: (2022-03-01) -
Evaluation of Potential miR-221, miR-93, miR-21, and miR-24 as Molecular Markers for Laryngeal Squamous Cell Carcinoma
by: Habib Azimi, et al.
Published: (2025-07-01) -
MicroRNA MiR-21 and MiR-155 are new markers for breast cancer
by: M. A. Taipov, et al.
Published: (2014-07-01) -
miR-155 and miR-223 as markers of biological and clinical features of chronic lymphocytic leukemia
by: M. L. Perepechaeva, et al.
Published: (2024-03-01)